Your weekly roundup of the latest news from Drug Topics®.
The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.
VP-102 hopes to treat molluscum contagiosum, pending approval from FDA
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
The PDFUA date for the drug is October 13, 2023.